This report presents a strategic analysis of the Canada Artificial Intelligence (AI) in Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada Artificial Intelligence (AI) in Healthcare Market, offering unmatched value, accuracy and expert insights.
Canada is the western hemisphere's largest country and one of the world's largest. It has a vibrant free-market economy, with businesses ranging from small owner-managed enterprises to multinational companies. Historically, Canada's economy was built on the export of agricultural staples, particularly grain, as well as the manufacture and sale of natural resource exports including minerals, oil and gas, and forest products.
Canada’s mixed public-private healthcare system consists of the public sector, which finances healthcare services, and the private sector, which delivers these services. There is currently no uniform procurement model in place across the country. Each province has its own set of rules, which are frequently varied among regions or providers. Healthcare procurement reforms, including centralized attempts, are being implemented or investigated by provincial governments across Canada.
Digital healthcare is developing globally as a result of IT technology development and the emergence of remote patient monitoring (RPM) solutions. RPM has developed into a useful tool for enhancing clinical assessment and decision-making while lowering the likelihood of hospitalization. With the prevalence of cancer, diabetes and cardiovascular diseases rising, RPM service use is also anticipated to rise. Additionally, as the aging population grows, more of them are choosing independent, healthy lifestyles, which will probably increase the adoption of RPM solutions.
Artificial intelligence for the healthcare sector and related specialists came out as a blessing in this crisis. Eletimes.com states that Artificial Intelligence (AI) technology has the capacity to automatically mine through news articles and web information from all over the world, assisting healthcare professionals in identifying recurring irregularities that could result in an epidemic or, worse yet, a pandemic. By retrieving information about diseases, this technology may also assist the globe to survive a pandemic that is about to strike.
Market Size and Key Findings
The North America Artificial Intelligence (AI) in Healthcare market is estimated to be valued at US$ 11.6 Bn in 2021 and is expected to exhibit a CAGR of 37% over the forecast period (2021-2030).
Market Growth Drivers Analysis
Care providers can now diagnose patients' underlying medical issues early thanks to deep learning technologies, predictive analytics, content analytics, and Natural Language Processing (NLP) tools. The Covid-19 outbreak increased demand for AI technology and made these sophisticated technologies' potential more apparent. Healthcare systems extensively embraced these technologies for the quick diagnosis and detection of various virus strains and made use of tailored data to enhance outbreak management. In order to quickly and accurately diagnose patients who tested positive for Covid-19, AI/ML algorithms were used in the diagnosis field. These technologically advanced modules were trained using datasets of chest CT scans, symptoms, pathological findings, and exposure history.
Rapid developments in this field, such as the intravascular delivery of bone marrow-derived stem cells employing autologous stem cell therapy for treating brain injury, are also expected to support the segment's expansion through 2022. Given the increased prevalence of disorders like cerebral stroke, cerebral balloon angioplasty—a type of interventional Artificial Intelligence (AI) in Healthcare—is anticipated to develop profitably over the projected period. In addition, a strong preference for pairing cerebral stents with angioplasty in order to prevent carotid plaque from reaccumulating in the afflicted vessels is anticipated to spur the expansion of this sub-segment in the upcoming years.
Key Players
The prominent players operating in this market include Nuance Communications, Inc., IBM Corporation, Microsoft, NVIDIA Corporation, Intel Corporation, DeepMind Technologies Limited, etc.
1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
The Artificial Intelligence (AI) in Healthcare Market is segmented as mentioned below:
By Healthcare Component (Revenue, USD Billion):
By Healthcare Applications (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.